Patents by Inventor Jean-Luc Imler

Jean-Luc Imler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Defective adenoviruses and corresponding complementation lines
    Patent number: 7067309
    Abstract: Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: June 27, 2006
    Assignee: Transgene S.A.
    Inventors: Jean-Luc Imler, Majid Mehtali, Andréa Pavirani
  • Defective adenoviruses and corresponding complementation lines
    Patent number: 7005277
    Abstract: Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: February 28, 2006
    Assignee: Transgene S.A.
    Inventors: Jean-Luc Imler, Majid Mehtali, Andréa Pavirani
  • Defective adenoviruses and corresponding complementation lines
    Publication number: 20030170885
    Abstract: Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Application
    Filed: December 19, 2000
    Publication date: September 11, 2003
    Inventors: Jean-Luc Imler, Majid Mehtali, Andrea Pavirani
  • Defective adenoviruses and corresponding complementation lines
    Publication number: 20010049136
    Abstract: Novel eective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Application
    Filed: November 30, 2000
    Publication date: December 6, 2001
    Inventors: Jean-Luc Imler, Majid Mehtali, Andrea Pavirani
  • Defective adenoviruses and corresponding complementation lines
    Patent number: 6133028
    Abstract: Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: October 17, 2000
    Assignee: Transgene S.A.
    Inventors: Jean-Luc Imler, Majid Mehtali, Andrea Pavirani
  • Defective adenoviruses and corresponding complementation lines
    Patent number: 6040174
    Abstract: Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.
    Type: Grant
    Filed: January 26, 1995
    Date of Patent: March 21, 2000
    Assignee: Transgene S.A.
    Inventors: Jean-Luc Imler, Majid Mehtali, Andrea Pavirani